SARS-CoV-2 Spike Glycoprotein RBD Nanobody (FITC)
SARS-CoV-2 Spike Glycoprotein RBD Nanobody is a Recombinant Human Monoclonal antibody conjugated to FITC for the detection of Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) SARS-CoV-2 Spike Glycoprotein RBD. This antibody contains VHH fused with Human IgG1 Fc at the C-terminus.
Supplier | Abbexa Ltd. |
---|---|
Product # | abx402248-50UL |
Pricing | 50 µl USD $536.5 |
Clonality | Monoclonal |
Conjugation | FITC |
Host | Human |
UniProt Primary AC | P0DTC2 |
Dry Ice | No |
Availability | Shipped within 5-10 working days. |
Note | This product is for research use only. |